As OxyContin patent expires, US says generic versions must contain changes to thwart abuse

WASHINGTON – U.S. health regulators will require generic versions of the bestselling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

Afficher le reportage au complet